Jefferies Financial Group Has Lowered Expectations for Teladoc Health (NYSE:TDOC) Stock Price

Teladoc Health (NYSE:TDOC) had its target price decreased by Jefferies Financial Group from $10.00 to $8.00 in a research report sent to investors on Monday morning,Benzinga reports. Jefferies Financial Group currently has a hold rating on the health services provider’s stock.

TDOC has been the topic of a number of other research reports. The Goldman Sachs Group cut their price target on shares of Teladoc Health from $16.00 to $13.00 and set a “buy” rating on the stock in a report on Monday, March 3rd. Piper Sandler reduced their price target on Teladoc Health from $13.00 to $12.00 and set an “overweight” rating on the stock in a research report on Thursday, February 27th. Needham & Company LLC reissued a “hold” rating on shares of Teladoc Health in a research note on Thursday, February 27th. Bank of America cut their price objective on Teladoc Health from $9.50 to $8.00 and set a “neutral” rating on the stock in a research note on Friday, April 11th. Finally, Oppenheimer reduced their target price on Teladoc Health from $14.00 to $12.00 and set an “outperform” rating on the stock in a report on Friday, January 24th. Eleven analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $10.82.

Teladoc Health Trading Down 4.5 %

NYSE TDOC opened at $6.52 on Monday. The company has a market cap of $1.14 billion, a price-to-earnings ratio of -1.13 and a beta of 1.73. Teladoc Health has a twelve month low of $6.35 and a twelve month high of $15.21. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66. The business’s fifty day moving average is $9.05 and its 200 day moving average is $9.62.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings results on Wednesday, February 26th. The health services provider reported ($0.28) EPS for the quarter, missing analysts’ consensus estimates of ($0.21) by ($0.07). Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. The firm had revenue of $640.49 million for the quarter, compared to analyst estimates of $639.44 million. As a group, sell-side analysts expect that Teladoc Health will post -1.16 EPS for the current fiscal year.

Insider Activity

In other news, insider Adam C. Vandervoort sold 11,011 shares of the business’s stock in a transaction that occurred on Thursday, March 20th. The stock was sold at an average price of $8.42, for a total transaction of $92,712.62. Following the completion of the sale, the insider now owns 64,308 shares in the company, valued at $541,473.36. The trade was a 14.62 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Company insiders own 0.95% of the company’s stock.

Institutional Trading of Teladoc Health

Several hedge funds have recently bought and sold shares of the business. Arizona State Retirement System raised its stake in shares of Teladoc Health by 1.8% in the fourth quarter. Arizona State Retirement System now owns 49,691 shares of the health services provider’s stock worth $452,000 after purchasing an additional 859 shares during the last quarter. Mercer Global Advisors Inc. ADV lifted its stake in Teladoc Health by 9.6% during the 4th quarter. Mercer Global Advisors Inc. ADV now owns 12,456 shares of the health services provider’s stock valued at $113,000 after acquiring an additional 1,089 shares in the last quarter. Canada Pension Plan Investment Board boosted its holdings in Teladoc Health by 0.5% during the 4th quarter. Canada Pension Plan Investment Board now owns 228,700 shares of the health services provider’s stock worth $2,079,000 after acquiring an additional 1,200 shares during the last quarter. Summit Investment Advisors Inc. grew its stake in shares of Teladoc Health by 8.0% in the 4th quarter. Summit Investment Advisors Inc. now owns 18,009 shares of the health services provider’s stock worth $164,000 after acquiring an additional 1,331 shares in the last quarter. Finally, Vise Technologies Inc. raised its holdings in shares of Teladoc Health by 4.9% in the fourth quarter. Vise Technologies Inc. now owns 30,179 shares of the health services provider’s stock valued at $274,000 after purchasing an additional 1,405 shares during the last quarter. Institutional investors and hedge funds own 76.82% of the company’s stock.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.